Treatment attrition rates and relevant risk factors in multiple myeloma: a real-world study in

HIGHLIGHTS

• who: . and collaborators from the University of Strathclyde, United Kingdom have published the article: Treatment attrition rates and relevant risk factors in multiple myeloma: A real-world study in, in the Journal: (JOURNAL) of 31/Oct/2021
• what: The authors aim to elucidate the attrition rates of separate LOTs and their associated risk factors in Chinese MM patients by collecting real-world data from the West China Hospital Sichuan University (WCHSCU). This study demonstrated that MM frontline therapies in China are distinct from the authors and Western countries.
• how: To understand the attrition . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.